Form 4: Capital Bancorp CMO's Equity Transactions Detailed

Sentiment:

Insider Transaction Report


Capital Bancorp's EVP, Chief Marketing Officer, Jeffrey Kaye, reported recent acquisitions of restricted stock units and stock options, alongside the vesting and tax-related disposition of common stock.

Summary

  • Jeffrey Kaye, EVP, Chief Marketing Officer of Capital Bancorp Inc. (CBNK), reported several equity transactions.
  • On March 3, 2026, 208 shares of common stock were acquired through the exercise or vesting of derivative securities.
  • Concurrently, 74 shares of common stock were disposed of at a price of $29.82 per share, likely for tax withholding purposes.
  • Following these transactions, Mr. Kaye beneficially owns 134 shares of common stock directly.
  • On March 2, 2026, Mr. Kaye was granted 863 new Restricted Stock Units (RSUs) which will vest in four equal annual installments beginning March 2, 2027.
  • Also on March 2, 2026, Mr. Kaye was granted 3,335 new stock options with an exercise price of $29.41, vesting in four equal annual installments starting March 2, 2027, and expiring on March 2, 2031.
  • An additional 208 Restricted Stock Units vested on March 3, 2026, which will vest in four equal annual installments beginning March 3, 2026.
  • Mr. Kaye also holds existing stock options with various exercise prices and vesting schedules, totaling 10,893 options.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction reflecting compensation and equity incentives, with new grants indicating continued alignment of executive interests with shareholders.

Positives

  • Acquisition of 208 shares of common stock, indicating vesting or exercise of previously granted equity.
  • Grant of 863 new Restricted Stock Units (RSUs) on March 2, 2026, aligning executive interests with long-term shareholder value.
  • Grant of 3,335 new stock options on March 2, 2026, providing further incentive for executive performance.
  • Continued equity ownership by a key executive, demonstrating commitment to the company.

Negatives

  • Disposition of 74 shares of common stock at $29.82 per share, likely for tax obligations related to equity vesting, which reduces direct ownership.

Future Outlook

The filing details future vesting schedules for Restricted Stock Units and Stock Options, indicating that 863 RSUs and 3,335 stock options will vest in four equal annual installments beginning March 2, 2027. Additionally, 208 RSUs will vest in four equal annual installments beginning March 3, 2026.

Industry Context

StockSavvy.ai notes that insider transaction filings like this Form 4 provide transparency into executive compensation and equity ownership, which can be a signal for market participants regarding management's alignment with shareholder interests. These routine grants and vesting events are common in the financial services industry to incentivize long-term performance.

Stakeholder Impact

  • Shareholders: Provides transparency into executive compensation and equity ownership, demonstrating management's vested interest in the company's long-term performance.

Next Steps

  • Vesting of 863 Restricted Stock Units in four equal annual installments beginning March 2, 2027.
  • Vesting of 3,335 Stock Options in four equal annual installments beginning March 2, 2027.
  • Vesting of 208 Restricted Stock Units in four equal annual installments beginning March 3, 2026.

Key Dates

DateDescription
01/01/2024Start of vesting for 3,685 stock options.
01/01/2025Start of vesting for 4,130 stock options.
03/02/2026Date of grant for 863 Restricted Stock Units and 3,335 Stock Options.
03/03/2026Date of common stock acquisition (208 shares) and disposition (74 shares). Also, start of vesting for 208 Restricted Stock Units and 3,078 stock options.
03/04/2026Date the Form 4 was signed.
03/02/2027Start of vesting for 863 Restricted Stock Units and 3,335 Stock Options.
01/01/2028Expiration date for 3,685 stock options.
01/01/2029Expiration date for 4,130 stock options.
03/03/2030Expiration date for 3,078 stock options.
03/02/2031Expiration date for 3,335 stock options.

Recommendation

hold

This Form 4 details routine equity compensation and vesting for a key executive. While it shows continued alignment of management interests with shareholders through new grants, it does not present new information that would fundamentally alter the investment thesis for Capital Bancorp Inc. Investors should consider this in the context of the company's overall financial performance and strategic outlook.

Keywords

Capital Bancorp Inc, CBNK, Jeffrey Kaye, Insider Transaction, Form 4, Restricted Stock Units, Stock Options, Equity Compensation, Executive Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.